Investors Strapped Rocket Corcept: Why the Stock Jumped on Wednesday
A pivotal FDA decision sent Corcept Therapeutics stock soaring. This guide explains the news, what it could mean for ...
Retirees benefit from selecting tax-efficient asset classes and optimized withdrawal sequencing. Learn which classes to favor and why.
23,930 articlesA pivotal FDA decision sent Corcept Therapeutics stock soaring. This guide explains the news, what it could mean for ...
UBS raises Nucor to Buy with a $190 target after a pullback, highlighting stronger than expected Q1 guidance and impr...
A surge of early arrivals has prompted airports to change guidance, arguing that arriving too early can slow lines fo...
After a sharp early-2026 retreat, Shopify looks set to re-rate as cash flow strengthens, a new buyback supports the s...
Struggling to price a fix up? This guide shows you how to estimate rehab costs from scratch, step by step, with clear...
As AI accelerates efficiency, middle managers face restructuring across industries. Investors are weighing earnings i...
Apple sits around $284 as traders weigh the next move. A robust quarter and expanding Services set the stage for a bu...
A high-stakes rehearsal moment sparked a broader look at how money, contracts, and workplace culture intersect in the...
Vericel faces a pivotal 2026 earnings season. This guide breaks down the drivers behind the numbers, what to watch in...
A high-stakes clash over FCC rules has echoes for your wallet. This article breaks down how regulatory battles around...
Apple and Microsoft posted strong earnings as the AI battle tightens. Microsoft leads on monetizing generative AI, wh...
Saudi Aramco’s CEO cautioned that oil markets may not normalize until 2027 as Strait of Hormuz disruptions persist, i...